
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United Kingdom heart valve devices market was valued at USD 3.69 Billion in 2024, driven by the increasing incidence of valvular heart diseases such as aortic stenosis and mitral regurgitation in the region. The market is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034, with the values likely to reach USD 9.14 Billion by 2034.
Base Year
Historical Period
Forecast Period
The United Kingdom is reported to experience a growing burden of valvular heart diseases, such as aortic stenosis and mitral regurgitation, particularly in people over 65, which is likely to boost market growth.
The presence of a favorable regulatory system, led by the MHRA (Medicines and Healthcare products Regulatory Agency) and NHS England, is projected to elevate the United Kingdom heart valve devices market value in the forecast period.
The rising interest in customized, retrievable, and repositionable valves, especially for complex anatomies and younger patients, is a major market trend.
Value in USD Billion
2025-2034
United Kingdom Heart Valve Devices Market Outlook
*this image is indicative*
The market is experiencing significant growth, driven by advancements in medical technology, an aging population, and increasing awareness of cardiovascular health. The UK's aging population is another key market driver, as valvular heart diseases such as aortic stenosis and mitral regurgitation are more common among older individuals. The demand for biological (tissue) valves, which require less long-term care compared to mechanical valves, is particularly high, aligning with healthcare preferences for less invasive, patient-friendly treatments. Moreover, the growing awareness of cardiovascular health, coupled with the NHS's initiatives to improve cardiovascular care, is expected to support the market expansion in the forecast period.
Rising Prevalence of Cardiovascular Diseases to Support Market Growth
Heart valve disease is prevalent in the United Kingdom, affecting approximately 11.3% of people over the age of 65. The rising burden of heart valve disease, particularly among the aging population, is a primary driver of growth in the heart valve devices market. As individuals age, the incidence of valvular heart diseases like aortic stenosis and mitral regurgitation increases, further contributing to the demand for effective valve replacement and repair solutions.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Valve Type
Market Breakup by Product Type
Market Breakup by Procedure
Market Breakup by End User
Segmentation Based on Valve Type to Hold a High Market Value
Based on the valve type, the market is segmented into biological (tissue) valve and mechanical valve. In the United Kingdom, the biological (tissue) valve segment holds a substantial market share, primarily due to its growing preference among elderly patients and those looking to avoid long-term anticoagulation therapy required with mechanical valves. These valves are increasingly used in both surgical and transcatheter procedures, including TAVR, and are supported by evolving clinical guidelines that favor tissue valves for patients over a certain age or with lifestyle considerations.
The market shows varied growth patterns across different regions, influenced by healthcare accessibility, demographic profiles, and the distribution of specialized cardiac centers. In Northern England, treatment rates are notably higher, indicating more active adoption of valve interventions in certain areas. On the other hand, Southern regions tend to show relatively lower treatment rates, revealing opportunities for further market development and improved access to advanced cardiac care.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc, headquartered in Ireland, offers a comprehensive range of transcatheter and surgical heart valves. The company's Evolut platform is widely used across NHS trusts and private hospitals, offering alternatives for patients unfit for open-heart surgery. Medtronic supports UK-based training programs, clinical trials, and registry data collection, helping to shape clinical guidelines and improve access to advanced care.
Edwards Lifesciences is a U.S.-based company specializing in structural heart disease, critical care, and surgical monitoring technologies. In the UK, the company has made a significant impact with its SAPIEN transcatheter valve series, which is widely used across NHS and private hospitals. Edwards actively collaborates on clinical research and national registry programs, helping to validate the safety and long-term effectiveness of its devices.
Abbott is recognized for its role in expanding transcatheter mitral valve repair (TMVr) in the UK, particularly through its MitraClip system. MitraClip has become a leading therapeutic option for patients with mitral regurgitation who are not suitable candidates for open-heart surgery. Abbott has also reinforced its presence in the transcatheter aortic valve replacement (TAVR) space with the introduction of the Portico and Navitor systems.
Corcym is one of the key market players in the surgical heart valve segment. Its sutureless valve technology (Perceval) enables faster surgical procedures and recovery, making it a valuable solution in high-volume centers. The company contributes to ongoing UK cardiac surgery education and partners with surgeons to optimize outcomes for complex valve repair and replacement cases.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boston Scientific Corporation, B. Braun SE, Getinge AB, JenaValve Technology, Inc., and Meril Life Sciences Pvt. Ltd.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Valve Type |
|
Breakup by Product Type |
|
Breakup by Procedure |
|
Breakup by End User |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share